rs2848477

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004268.5(MED17):​c.207G>C​(p.Glu69Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.62 in 1,546,188 control chromosomes in the GnomAD database, including 302,643 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 25275 hom., cov: 33)
Exomes 𝑓: 0.63 ( 277368 hom. )

Consequence

MED17
NM_004268.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.209

Publications

33 publications found
Variant links:
Genes affected
MED17 (HGNC:2375): (mediator complex subunit 17) The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. [provided by RefSeq, Jul 2008]
MED17 Gene-Disease associations (from GenCC):
  • infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.3689065E-6).
BP6
Variant 11-93784720-G-C is Benign according to our data. Variant chr11-93784720-G-C is described in ClinVar as Benign. ClinVar VariationId is 129601.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.729 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED17NM_004268.5 linkc.207G>C p.Glu69Asp missense_variant Exon 1 of 12 ENST00000251871.9 NP_004259.3 Q9NVC6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED17ENST00000251871.9 linkc.207G>C p.Glu69Asp missense_variant Exon 1 of 12 1 NM_004268.5 ENSP00000251871.3 Q9NVC6-1
ENSG00000284057ENST00000638767.1 linkc.768G>C p.Glu256Asp missense_variant Exon 8 of 19 5 ENSP00000492220.1 A0A1W2PRB8

Frequencies

GnomAD3 genomes
AF:
0.559
AC:
84751
AN:
151632
Hom.:
25262
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.334
Gnomad AMI
AF:
0.575
Gnomad AMR
AF:
0.704
Gnomad ASJ
AF:
0.590
Gnomad EAS
AF:
0.748
Gnomad SAS
AF:
0.594
Gnomad FIN
AF:
0.668
Gnomad MID
AF:
0.573
Gnomad NFE
AF:
0.627
Gnomad OTH
AF:
0.585
GnomAD2 exomes
AF:
0.646
AC:
97056
AN:
150320
AF XY:
0.642
show subpopulations
Gnomad AFR exome
AF:
0.333
Gnomad AMR exome
AF:
0.793
Gnomad ASJ exome
AF:
0.583
Gnomad EAS exome
AF:
0.751
Gnomad FIN exome
AF:
0.673
Gnomad NFE exome
AF:
0.632
Gnomad OTH exome
AF:
0.618
GnomAD4 exome
AF:
0.627
AC:
874344
AN:
1394438
Hom.:
277368
Cov.:
76
AF XY:
0.627
AC XY:
431532
AN XY:
688248
show subpopulations
African (AFR)
AF:
0.324
AC:
10391
AN:
32100
American (AMR)
AF:
0.780
AC:
27867
AN:
35740
Ashkenazi Jewish (ASJ)
AF:
0.585
AC:
14719
AN:
25166
East Asian (EAS)
AF:
0.763
AC:
27779
AN:
36402
South Asian (SAS)
AF:
0.598
AC:
47584
AN:
79528
European-Finnish (FIN)
AF:
0.658
AC:
27254
AN:
41398
Middle Eastern (MID)
AF:
0.589
AC:
3146
AN:
5342
European-Non Finnish (NFE)
AF:
0.629
AC:
679936
AN:
1080686
Other (OTH)
AF:
0.614
AC:
35668
AN:
58076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
18788
37575
56363
75150
93938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18302
36604
54906
73208
91510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.559
AC:
84790
AN:
151750
Hom.:
25275
Cov.:
33
AF XY:
0.564
AC XY:
41835
AN XY:
74134
show subpopulations
African (AFR)
AF:
0.334
AC:
13821
AN:
41426
American (AMR)
AF:
0.704
AC:
10743
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.590
AC:
2046
AN:
3468
East Asian (EAS)
AF:
0.749
AC:
3840
AN:
5128
South Asian (SAS)
AF:
0.596
AC:
2872
AN:
4822
European-Finnish (FIN)
AF:
0.668
AC:
7019
AN:
10510
Middle Eastern (MID)
AF:
0.571
AC:
168
AN:
294
European-Non Finnish (NFE)
AF:
0.627
AC:
42527
AN:
67826
Other (OTH)
AF:
0.582
AC:
1231
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1829
3658
5486
7315
9144
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.601
Hom.:
8245
Bravo
AF:
0.554
TwinsUK
AF:
0.634
AC:
2351
ALSPAC
AF:
0.634
AC:
2444
ESP6500AA
AF:
0.369
AC:
1525
ESP6500EA
AF:
0.642
AC:
5300
ExAC
AF:
0.544
AC:
49987
Asia WGS
AF:
0.611
AC:
2122
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly Benign:4
May 31, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 18, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Dec 28, 2012
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
10
DANN
Benign
0.69
DEOGEN2
Benign
0.054
.;T;.;.;.;.;.
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.55
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.22
T;T;T;T;T;T;T
MetaRNN
Benign
0.0000024
T;T;T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.4
.;L;.;.;.;.;.
PhyloP100
0.21
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-0.20
.;N;.;N;.;.;.
REVEL
Benign
0.19
Sift
Benign
0.87
.;T;.;T;.;.;.
Sift4G
Benign
0.44
.;T;.;T;.;.;.
Polyphen
0.0
.;B;.;.;.;.;.
Vest4
0.018
MutPred
0.40
.;Gain of helix (P = 0.027);Gain of helix (P = 0.027);Gain of helix (P = 0.027);Gain of helix (P = 0.027);Gain of helix (P = 0.027);Gain of helix (P = 0.027);
MPC
0.25
ClinPred
0.0029
T
GERP RS
1.7
PromoterAI
0.0011
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.075
gMVP
0.24
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2848477; hg19: chr11-93517886; COSMIC: COSV52599620; COSMIC: COSV52599620; API